Glucose-Na-K Baxter

Glucose-Na-K Baxter is an intravenous solution containing magnesium chloride hexahydrate, potassium chloride, sodium chloride, glucose, and sodium acetate trihydrate. It is supplied as a sterile fluid for infusion, without a specified strength, and is marketed in the European Union as a prescription‑only electrolyte replacement product. It is intended for use by healthcare professionals to restore fluid volume and correct electrolyte and glucose imbalances in acute care settings.

Glucose-Na-K Baxter is used in clinical situations where rapid fluid and electrolyte replacement is required.

- Fluid and electrolyte replacement in patients with dehydration or volume loss. - Management of hypoglycemia when glucose supplementation is needed. - Post‑operative care to maintain electrolyte balance and support recovery. - Treatment of acute electrolyte disturbances such as hyponatremia, hypokalemia, or hypomagnesemia. - Support during renal replacement therapy or continuous infusion procedures. - Adjunct therapy in severe burns or trauma to replenish lost salts and glucose.

Potential adverse reactions to Glucose-Na-K Baxter are generally related to its electrolyte composition and infusion characteristics.

Common: - Mild irritation or pain at the infusion site. - Transient increase in blood sodium or potassium levels. - Nausea or mild gastrointestinal discomfort. - Slight rise in blood glucose concentration. - Local swelling or edema at the infusion site.

Serious: - Hypermagnesemia leading to muscle weakness or cardiac arrhythmia. - Severe electrolyte imbalance causing cardiac conduction disturbances. - Allergic reaction such as rash, itching, or anaphylaxis. - Pulmonary edema from rapid fluid overload.

When prescribing or administering Glucose-Na-K Baxter, clinicians should consider several safety precautions to minimize risks.

- Assess baseline electrolyte levels and renal function before infusion. - Adjust infusion rate in patients with cardiac or renal impairment. - Monitor blood glucose closely in diabetic or hypoglycemic patients. - Avoid rapid large-volume administration to prevent fluid overload. - Use aseptic technique to reduce infection risk. - Consider compatibility with other intravenous medications before co‑administration. - Discontinue if signs of severe electrolyte disturbance or allergic reaction appear.

Glucose-Na-K Baxter may interact with other drugs administered intravenously or orally, affecting electrolyte balance or drug efficacy.

Avoid: - Avoid concurrent infusion of potassium‑sparing diuretics that may cause hyperkalemia. - Do not mix with calcium‑containing solutions, which can precipitate insoluble salts.

Use with caution: - Use cautiously with other magnesium‑containing products to prevent hypermagnesemia. - Monitor closely when combined with insulin or oral hypoglycemics due to additive glucose effects. - Adjust dosing when given with loop diuretics that alter sodium and potassium excretion. - Be careful with nephrotoxic agents, as electrolyte shifts may exacerbate renal injury.